Cognitive functioning in euthymic bipolar I and bipolar II patients

Bipolar Disorders

Volumn 10, Issue 8, 2008, Pages 877-887

  Dittmann, Sandra ^a   Henning Fast, Kristina ^a   Gerber, Sonja ^b   Seemüller, Florian ^a   Riedel, Michael ^a   Severus, W Emanuel ^a   Langosch, Jens ^b   Engel, Rolf R ^a   Möller, Hans Jürgen ^a   Grunze, Heinz C ^c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Bipolar I disorder; Bipolar II disorder; Cognition; Neuropsychological functioning

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; LITHIUM SALT; MOOD STABILIZER; NEUROLEPTIC AGENT; VALPROIC ACID;

ADULT; APTITUDE TEST; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL ASSESSMENT; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE DURATION; FEMALE; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENTAL PERFORMANCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; PSYCHOMOTOR ACTIVITY; PSYCHOMOTOR DISORDER; PSYCHOSIS; PSYCHOSOCIAL CARE; STRUCTURED INTERVIEW; VISUAL FIELD DEFECT; WORKING MEMORY;

ADULT; ATTENTION; BIPOLAR DISORDER; COGNITION DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PROBLEM SOLVING; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; REFERENCE VALUES; RETENTION (PSYCHOLOGY); RISK FACTORS; VERBAL LEARNING; YOUNG ADULT;

EID: 56349148767     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2008.00640.x     Document Type: Article

References (57)

1. Quraishi S, Frangou S. Neuropsychology of bipolar disorder: A review. J Affect Disord 2002; 72: 209-226.
2. Malhi GS, Ivanovski B, Szekeres V, Olley A. Bipolar disorder: It's all in your mind? The neuropsychological profile of a biological disorder. Can J Psychiatry 2004; 49: 813-819.
3. Martínez-Arán A, Vieta E, Colom F et al. Cognitive impairment in euthymic bipolar patients: Implications for clinical and functional outcome. Bipolar Disord 2004; 6: 224-232.
4. Martínez-Arán A, Vieta E, Reinares M et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004; 161: 262-270.
5. Clark L, Iversen SD, Goodwin GM. Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002; 180: 313-319.
6. Clark L, Kempton MJ, Scarna A, Grasby PM, Goodwin GM. Sustained attention-deficit confirmed in euthymic bipolar disorder but not in first-degree relatives of bipolar patients or euthymic unipolar depression. Biol Psychiatry 2005; 57: 183-187.
7. Glahn DC, Bearden CE, Cakir S et al. Differential working memory impairment in bipolar disorder and schizophrenia: Effects of lifetime history of psychosis. Bipolar Disord 2006; 8: 117-123.
8. Ferrier IN, Stanton BR, Kelly TP, Scott J. Neuropsychological function in euthymic patients with bipolar disorder. Br J Psychiatry 1999; 175: 246-251.
9. Altshuler LL, Ventura J, van Gorp WG, Green MF, Theberge DC, Mintz J. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects. Biol Psychiatry 2004; 56: 560-569.
10. Donaldson S, Goldstein LH, Landau S, Raymont V, Frangou S. The Maudsley Bipolar Disorder Project: The effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder. J Clin Psychiatry 2003; 64: 86-93.
11. Frangou S, Donaldson S, Hadjulis M, Landau S, Goldstein LH. The Maudsley Bipolar Disorder Project: Executive dysfunction in bipolar disorder I and its clinical correlates. Biol Psychiatry 2005; 58: 859-864.
12. Torres IJ, Boudreau VG, Yatham LN. Neuropsychological functioning in euthymic bipolar disorder: A meta-analysis. Acta Psychiatr Scand 2007; 116 (Suppl. 434): 17-26.
13. Robinson LJ, Thompson JM, Gallagher P et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 2006; 93: 105-115.
14. Martínez-Arán A, Vieta E, Torrent C et al. Functional outcome in bipolar disorder: The role of clinical and cognitive factors. Bipolar Disord 2007; 9: 103-113.
15. Jaeger J, Berns S, Loftus S, Gonzalez C, Czobor P. Neurocognitive test performance predicts functional recovery from acute exacerbation leading to hospitalization in bipolar disorder. Bipolar Disord 2007; 9: 93-102.
16. Gruber SA, Rosso IM, Yurgelun-Todd D. Neuropsychological performance predicts clinical recovery in bipolar patients. J Affect Disord 2008; 105: 253-260.
17. Deckersbach T, Savage CR, Reilly-Harrington N, Clark L, Sachs G, Rauch SL. Episodic memory impairment in bipolar disorder and obsessive-compulsive disorder: The role of memory strategies. Bipolar Disord 2004; 6: 233-244.
18. Fleck DE, Shear PK, Strakowski SM. Processing efficiency and sustained attention in bipolar disorder. J Int Neuropsychol Soc 2005; 11: 49-57.
19. Krabbendam L, Honig A, Wiersma J et al. Cognitive dysfunctions and white matter lesions in patients with bipolar disorder in remission. Acta Psychiatr Scand 2000; 101: 274-280.
20. Dittmann S, Seemüller F, Schwarz M et al. Association of cognitive deficits with elevated homocysteine plasma levels in euthymic bipolar patients and its impact on psychosocial functioning: Preliminary results. Bipolar Disord 2007; 9: 63-70.
21. Dittmann S, Seemüller F, Grunze H et al. Elevated plasma homocysteine levels in euthymic bipolar patients and their impact on cognition. J Clin Psychiatry 2008; 69: 899-906.
22. Vieta E, Suppes T. Bipolar II disorder: Arguments for and against a distinct diagnostic entity. Bipolar Disord 2008; 10: 163-178.
23. Judd LL, Akiskal HS, Schettler PJ et al. The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders? J Affect Disord 2003; 73: 19-32.
24. Judd LL, Schettler PJ, Akiskal HS et al. Long-term symptomatic status of bipolar I vs. bipolar II disorders. Int J Neuropsychopharmacol 2003; 6: 127-137.
25. Vieta E, Gasto C, Otero A, Nieto E, Vallejo J. Differential features between bipolar I and bipolar II disorder. Compr Psychiatry 1997; 38: 98-101.
26. Ruggero CJ, Chelminski I, Young D, Zimmerman M. Psychosocial impairment associated with bipolar II disorder. J Affect Disord 2007; 104: 53-60.
27. Maina G, Albert U, Bellodi L et al. Health-related quality of life in euthymic bipolar disorder patients: Differences between bipolar I and II subtypes. J Clin Psychiatry 2007; 68: 207-212.
28. Judd LL, Schettler PJ, Solomon DA et al. Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders. J Affect Disord 2008; 65: 386-394.
29. Glahn DC, Bearden CE, Niendam TA, Escamilla MA. The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder. Bipolar Disord 2004; 6: 171-182.
30. Summers M, Papadopoulou K, Bruno S, Cipolotti L, Ron MA. Bipolar I and bipolar II disorder: Cognition and emotion processing. Psychol Med 2006; 36: 1799-1809.
31. Torrent C, Martínez-Arán A, Daban C et al. Cognitive impairment in bipolar II disorder. Br J Psychiatry 2006; 189: 254-259.
32. Taylor Tavares JV, Clark L, Cannon DM, Erickson K, Drevets WC, Sahakian BJ. Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II depression. Biol Psychiatry 2007; 62: 917-924.
33. Simonsen C, Sundet K, Vaskinn A et al. Neurocognitive profiles in bipolar I and bipolar II disorder: Differences in pattern and magnitude of dysfunction. Bipolar Disord 2008; 10: 245-255.
34. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test (CVLT). San Antonio, TX: The Psychological Corporation, 1987.
35. Kupka RW, Nolen WA, Altshuler LL et al. The Stanley Foundation Bipolar Network: 2. Preliminary summary of demographics, course of illness and response to novel treatments. Br J Psychiatry 2001; 178: S177-S183.
36. Leverich GS, Nolen WA, Rush AJ et al. The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. J Affect Disord 2001; 67: 33-44.
37. Dittmann S, Biedermann NC, Grunze H et al. The Stanley Foundation Bipolar Network: Results of the naturalistic follow-up study (NFS) after 2 1/2 years of follow-up in the German centres. Neuropsychobiology 2002; 46 (Suppl. 1): 2-9.
38. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-296.
39. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
40. First MB, Gibbon M, Spitzer RL. Structured Clinical Interviews for DSM IV Axis I Disorders (Research Version, 2/96 Final). New York, NY: Biometrics Research Department, NY State Psychiatric Institute, 1996, 1996.
41. Wittchen HU, Wunderlich U, Gruschwitz S, Zaudig M. Strukturiertes Klinisches Interview für DSM-IV. Göttingen: Hogrefe, 1997.
42. Randolph C, Tierney MC, Mohr E, Chase TN. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Preliminary clinical validity. J Clin Exp Neuropsychol 1998; 20: 310-319.
43. Reitan RM. Validity of the trailmaking test as an indication of organic brain damage. Percept Mot Skills 1958; 8: 271-276.
44. Tulsky T, Zhu J, Ledbetter MF. WAIS-III, WMS-III Technical Manual. San Antonio, TX: Psychological Corporation, 1997.
45. Tewes U. HAWIE-R, Hamburg-Wechsler Intelligenztest für Erwachsene, Revision 1991. Bern: Verlag Hans Huber, 1994.
46. Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment, 4th edn. Oxford, New York: Oxford University Press, 2004.
47. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
48. Selva G, Salazar J, Balanza-Martinez V et al. Bipolar I patients with and without a history of psychotic symptoms: Do they differ in their cognitive functioning? J Psychiatr Res 2007; 41: 265-272.
49. Deckersbach T, McMurrich S, Ogutha J, Savage CR, Sachs G, Rauch SL. Characteristics of non-verbal memory impairment in bipolar disorder: The role of encoding strategies. Psychol Med 2004; 34: 823-832.
50. Malhi GS, Ivanovski B, Hadzi-Pavlovic D, Mitchell PB, Vieta E, Sachdev P. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia. Bipolar Disord 2007; 9: 114-125.
51. Bearden CE, Hoffman KM, Cannon TD. The neuropsychology and neuroanatomy of bipolar affective disorder: A critical review. Bipolar Disord 2001; 3: 106-150.
52. Kocsis JH, Shaw ED, Stokes PE et al. Neuropsychologic effects of lithium discontinuation. J Clin Psychopharmacol 1993; 13: 268-275.
53. Honig A, Arts BM, Ponds RW, Riedel WJ. Lithium induced cognitive side-effects in bipolar disorder: A qualitative analysis and implications for daily practice. Int Clin Psychopharmacol 1999; 14: 167-171.
54. Stoll AL, Locke CA, Vuckovic A, Mayer PV. Lithium-associated cognitive and functional deficits reduced by a switch to divalproex sodium: A case series. J Clin Psychiatry 1996; 57: 356-359.
55. Gualtieri CT, Johnson LG. Comparative neurocognitive effects of 5 psychotropic anticonvulsants and lithium. MedGenMed 2006; 8: 46.
56. Joffe RT, MacDonald C, Kutcher SP. Lack of differential cognitive effects of lithium and carbamazepine in bipolar affective disorder. J Clin Psychopharmacol 1988; 8: 425-428.
57. Goswami U, Sharma A, Khastigir U et al. Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder. Br J Psychiatry 2006; 188: 366-373.